International Society of Pharmacogenomics

International Society of Pharmacogenomics (ISP)


Journal

This site was not designed for Mac IE as Apple no longer supports Microsoft's Internet Explorer web browser. If you are on a Mac, please use Safari or Firefox for a better web surfing experience.

 

The Pharmacogenomics Journal: the official journal of the International Society of Pharmacogenomics (ISP)

Editor Julio Licinio1

1UCLA Center for Pharmacogenomics and Clinical Pharmacology, Email: licinio@miami.edu

Editorials

"Welcome to The Pharmacogenomics Journal"
The Pharmacogenomics Journal (2001) 1,1.

"The Pharmacogenomics Journal: the official journal of the International Society of Pharmacogenomics (ISP)"
The Pharmacogenomics Journal (2003) 3, 1.

What will change in The Pharmacogenomics Journal as it becomes ISP's official journal? We will maintain our format and editorial independence, which are crucial to our rapid growth and acceptance by the scientific community. A key factor in the success of a new title, such as ours, is editorial independence and fairness. For this reason, ISP will not be responsible for editorial decisions, which will remain the responsibility of the editor. By making The Pharmacogenomics Journal the official journal of the International Society for Pharmacogenomics, we hope to provide a forum to bring together society members and to publish peer-reviewed consensus documents that emerge from the activities of the society. Society members will also get a subscription to the journal at a reduced rate.view in PDF format



Manuscript submissions can be made electronically at the following website: http://mts-tpj.nature.com/cgi-bin/main.plex.

Available issues:
http://www.nature.com/tpj/archive/index.html

Nature's Web site:
http://www.nature.com/

Current Issue:
ALL articles from the most recent issue are freely available in HTML or PDF format. To access an article click on:
http://www.nature.com/tpj/index.html